Which supplements and vitamins interact with Bosulif (bosutinib)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Supplement and Vitamin Interactions with Bosulif (Bosutinib)

Avoid grapefruit products and St. John's wort entirely while taking Bosulif, and separate antacids/H2 blockers by at least 2 hours; avoid proton pump inhibitors or discuss alternatives with your doctor. 1

Critical Interactions to Avoid

Grapefruit and Grapefruit Extract

  • Complete avoidance required of grapefruit, grapefruit juice, and any supplements containing grapefruit extract 1
  • Grapefruit products significantly increase Bosulif levels in your body, potentially leading to dangerous toxicity
  • This occurs because grapefruit inhibits CYP3A4, the primary enzyme metabolizing bosutinib 2

St. John's Wort

  • Must be avoided completely 1
  • This herbal supplement can substantially alter Bosulif's effectiveness
  • Acts as a CYP3A4 inducer, potentially reducing bosutinib levels and compromising cancer treatment efficacy

Timing-Dependent Interactions

Antacids and H2 Blockers

  • Take at least 2 hours before OR 2 hours after Bosulif 1
  • Examples include: Tums, Maalox, famotidine (Pepcid), ranitidine
  • These medications can interfere with bosutinib absorption if taken simultaneously

Proton Pump Inhibitors (PPIs)

  • Discuss with your doctor or pharmacist before use 1
  • Examples include: omeprazole (Prilosec), esomeprazole (Nexium), lansoprazole (Prevacid)
  • May require alternative acid-reducing strategies or dose adjustments

Additional Herbal Supplement Considerations

Goldenseal and Berberine

While not mentioned in FDA labeling, recent research shows:

  • High-dose goldenseal extract may increase bosutinib exposure approximately 2-fold 3
  • High-dose berberine (300 mg three times daily) may increase bosutinib levels by approximately 30% 3
  • These interactions could increase side effect risk and may warrant dose adjustment if co-administration is necessary 3

Mechanism of Interactions

Bosutinib is primarily metabolized by the CYP3A4 enzyme system 2. Any supplement or vitamin that:

  • Inhibits CYP3A4 (like grapefruit, goldenseal) increases bosutinib levels → higher toxicity risk
  • Induces CYP3A4 (like St. John's wort) decreases bosutinib levels → reduced cancer treatment effectiveness

Clinical Pitfalls to Avoid

  • Always disclose ALL supplements and vitamins to your healthcare team, even those purchased over-the-counter or considered "natural" 1
  • Don't assume herbal products are safe simply because they're "natural" - they can have powerful drug interactions
  • Keep a written list of all supplements and show it to your doctor and pharmacist when starting Bosulif or adding new products
  • Be aware that multivitamins and protein powders may contain grapefruit extract - check ingredient labels carefully

What to Do

  1. Immediately stop grapefruit products and St. John's wort if currently taking
  2. Review all current supplements with your oncologist and pharmacist before continuing
  3. Time antacids/H2 blockers appropriately (2-hour separation)
  4. Discuss PPI alternatives with your healthcare provider if needed for acid reflux
  5. Report any new supplements before starting them during Bosulif treatment

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.